There are no approved therapeutic regimes for adrenal carcinoma following progression to a first line of chemotherapy/mitotane although a high percentage of patients are candidates to receive them. In the present article we review the possible therapeutic alternatives after the progression to a first line of treatment in patients with adrenal carcinoma and we report a case in which a prolonged overall survival is achieved, much higher than expected, probably in relation to the multidisciplinary management of the case and the use of most of the therapeutic arsenal available.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.5867/medwave.2017.06.7007 | DOI Listing |
Publication Analysis
Top Keywords
adrenal carcinoma
12
[palliative chemotherapy
4
chemotherapy metastatic
4
metastatic adrenal
4
carcinoma case
4
case report
4
report literature
4
literature review]
4
review] approved
4
approved therapeutic
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!